NUWE - Nuwellis Corp Trailing Twelve Months Revenue Growth

Nuwellis, Inc. (NUWE) is driving growth by expanding Aquadex systems into pediatrics and cardiology. The annual sales revenue trend over four quarters illustrates the market response, where 10.40 reflects the latest metric level. The company relies on a mature portfolio of fluid balance devices and adheres to ESG standards by minimizing plastic in the production of therapeutic equipment.
nuwellis.com (NUWE) - metric breakdowns and financial figures

This indicator compares revenue over the last twelve months with the same prior period, smoothing out short-term fluctuations to identify the actual business expansion trend. In the case of Nuwellis, Inc. (NUWE), the LTM sales growth YoY metric exposes the problem of slow expansion for ultrafiltration systems, where revenue stagnation amid high capital burn makes the free cash flow forecast uncertain.